Kukje Pharma Co., Ltd. (KRX:002720)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,245.00
+10.00 (0.24%)
Last updated: Nov 25, 2025, 12:52 PM KST

Kukje Pharma Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Net Income
7,1375,205-8,4153,557-1,5592,203
Upgrade
Depreciation & Amortization
3,1983,2034,2044,4884,4193,626
Upgrade
Asset Writedown & Restructuring Costs
36.1330.131,874502.66--
Upgrade
Loss (Gain) From Sale of Investments
182180.1-22.1116.73-13.21-149.32
Upgrade
Loss (Gain) on Equity Investments
----23.2172.9113.43
Upgrade
Provision & Write-off of Bad Debts
15.12349.37-1,249-1,313-1,2885,518
Upgrade
Other Operating Activities
3,8773,1111,7553,5502,3692,826
Upgrade
Change in Accounts Receivable
-5,592-2,334565.754,6484,5954,241
Upgrade
Change in Inventory
-2,860-949.391,290-4,7893,261-5,526
Upgrade
Change in Accounts Payable
8,339-4,39611,579711.15933.17-4,706
Upgrade
Change in Other Net Operating Assets
-3,384-458.16-8,006-4,845-3,192-2,947
Upgrade
Operating Cash Flow
10,9483,9403,5756,5049,5975,100
Upgrade
Operating Cash Flow Growth
189.79%10.20%-45.03%-32.23%88.18%41.52%
Upgrade
Capital Expenditures
-1,524-2,911-1,046-1,259-1,892-11,600
Upgrade
Sale of Property, Plant & Equipment
44.1110.35305.7481.4423.36890.02
Upgrade
Sale (Purchase) of Intangibles
-5.73-5.73--18-68.5-
Upgrade
Investment in Securities
68.3-1,746190--1,361-2,202
Upgrade
Other Investing Activities
-321.15-207.63-624.89-151.54-83.053,931
Upgrade
Investing Cash Flow
-1,739-4,760-1,175-1,347-3,382-8,981
Upgrade
Short-Term Debt Issued
-10,5007,900--5,351
Upgrade
Long-Term Debt Issued
-----2,000
Upgrade
Total Debt Issued
3,00010,5007,900--7,351
Upgrade
Short-Term Debt Repaid
--11,500-4,900-7,000-2,000-6,410
Upgrade
Long-Term Debt Repaid
--197.65-358.95-433.03-388.36-319.13
Upgrade
Total Debt Repaid
-2,180-11,698-5,259-7,433-2,388-6,729
Upgrade
Net Debt Issued (Repaid)
819.59-1,1982,641-7,433-2,388621.95
Upgrade
Repurchase of Common Stock
---31.07-40.62-45.54-
Upgrade
Dividends Paid
-610.88-----
Upgrade
Other Financing Activities
000000
Upgrade
Financing Cash Flow
208.72-1,1982,610-7,474-2,434621.95
Upgrade
Foreign Exchange Rate Adjustments
58.63105.8740.82-10.3871.65-176.3
Upgrade
Miscellaneous Cash Flow Adjustments
-0-----
Upgrade
Net Cash Flow
9,477-1,9115,051-2,3273,853-3,435
Upgrade
Free Cash Flow
9,4241,0292,5295,2457,705-6,500
Upgrade
Free Cash Flow Growth
740.99%-59.32%-51.78%-31.93%--
Upgrade
Free Cash Flow Margin
5.42%0.66%1.87%4.14%6.43%-4.98%
Upgrade
Free Cash Flow Per Share
462.9250.53124.88258.88380.18-320.63
Upgrade
Cash Interest Paid
980.991,2201,4181,003722.5734.31
Upgrade
Cash Income Tax Paid
1,6901,5622,269-559.712,4914,406
Upgrade
Levered Free Cash Flow
6,430-3,1358,5503,5045,485-4,106
Upgrade
Unlevered Free Cash Flow
7,031-2,3819,4504,1295,920-3,700
Upgrade
Change in Working Capital
-3,497-8,1385,429-4,2745,597-8,937
Upgrade
Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.